Other treatments for PD include monoamine oxidase inhibitors (MAO-B inhibitors), which aim to reduce the breakdown of the available dopamine, and dopamine agonists, which are designed to mimic dopamine, with the ability to cross the blood-brain barrier (BBB). Here, MAOB is linked to Parkinson disease.